Gd-DTPA and Gd-DOTA effects on metabolism of glucose and phosphatidylinositols.
Morris
T W
TW
Department of Radiology, University of Rochester Medical Center, New York.
Ekholm
S E
SE
Marinetti
G V
GV
Prentice
L I
LI
Leakey
P
P
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003287:Contrast Media / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005682:Gadolinium / Q000494:pharmacology*; D019786:Gadolinium DTPA; D005947:Glucose / Q000378:metabolism*; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D009942:Organometallic Compounds / Q000494:pharmacology*; D004369:Pentetic Acid / Q000494:pharmacology*; D010716:Phosphatidylinositols / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; D010716:Phosphatidylinositols; D004369:Pentetic Acid; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate; D005682:Gadolinium; D005947:Glucose; D019786:Gadolinium DTPA